Perrigo to sell Dermacosmetics business to KKR-managed Kairos for up to €327 million
Perrigo agreed on July 13, 2025 to sell its Dermacosmetics branded business in Northern Europe, the Netherlands and Poland to Kairos Bidco AB, a vehicle managed by an affiliate of KKR, for €300 million in upfront cash plus up to €27 million in contingent payments. The business generated about €125 million in 2024 net sales and about 5% of Perrigo's 2024 adjusted operating income, and the company says expected net proceeds will go toward balance sheet strengthening and other capital allocation priorities. The deal is expected to close in the first quarter of 2026, subject to regulatory approvals and works council consultation.
Key points
- Upfront cash of €300 million at closing, subject to customary adjustments for inventory, working capital, debt and cash
- Up to €27 million in additional contingent payments tied to performance thresholds over three years
- Business generated about €125 million in 2024 net sales and about 5% of 2024 adjusted operating income
- Expected closing in the first quarter of 2026; either party may terminate if closing is not completed within 18 months of signing
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 14, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.